Literature DB >> 22867780

Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.

Ben van Hout1, M F Janssen, You-Shan Feng, Thomas Kohlmann, Jan Busschbach, Dominik Golicki, Andrew Lloyd, Luciana Scalone, Paul Kind, A Simon Pickard.   

Abstract

BACKGROUND: A five-level version of the EuroQol five-dimensional (EQ-5D) descriptive system (EQ-5D-5L) has been developed, but value sets based on preferences directly elicited from representative general population samples are not yet available. The objective of this study was to develop values sets for the EQ-5D-5L by means of a mapping ("crosswalk") approach to the currently available three-level version of the EQ-5D (EQ-5D-3L) values sets.
METHODS: The EQ-5D-3L and EQ-5D-5L descriptive systems were coadministered to respondents with conditions of varying severity to ensure a broad range of levels of health across EQ-5D questionnaire dimensions. We explored four models to generate value sets for the EQ-5D-5L: linear regression, nonparametric statistics, ordered logistic regression, and item-response theory. Criteria for the preferred model included theoretical background, statistical fit, predictive power, and parsimony.
RESULTS: A total of 3691 respondents were included. All models had similar fit statistics. Predictive power was slightly better for the nonparametric and ordered logistic regression models. In considering all criteria, the nonparametric model was selected as most suitable for generating values for the EQ-5D-5L.
CONCLUSIONS: The nonparametric model was preferred for its simplicity while performing similarly to the other models. Being independent of the value set that is used, it can be applied to transform any EQ-5D-3L value set into EQ-5D-5L index values. Strengths of this approach include compatibility with three-level value sets. A limitation of any crosswalk is that the range of index values is restricted to the range of the EQ-5D-3L value sets.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2012        PMID: 22867780     DOI: 10.1016/j.jval.2012.02.008

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  554 in total

1.  An EQ-5D-5L value set based on Uruguayan population preferences.

Authors:  Federico Augustovski; Lucila Rey-Ares; Vilma Irazola; Osvaldo Ulises Garay; Oscar Gianneo; Graciela Fernández; Marcelo Morales; Luz Gibbons; Juan Manuel Ramos-Goñi
Journal:  Qual Life Res       Date:  2015-08-05       Impact factor: 4.147

2.  Health state utility instruments compared: inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D.

Authors:  Thor Gamst-Klaussen; Gang Chen; Admassu N Lamu; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2015-12-21       Impact factor: 4.147

3.  Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences.

Authors:  Cicely Kerr; Emily J Lloyd; Charlotte E Kosmas; Helen T Smith; James A Cooper; Karissa Johnston; Emma McIntosh; Andrew J Lloyd
Journal:  Qual Life Res       Date:  2015-12-01       Impact factor: 4.147

4.  Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.

Authors:  Rahul Bhatnagar; Ramon Luengo-Fernandez; Brennan C Kahan; Najib M Rahman; Robert F Miller; Nick A Maskell
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

5.  First-Year Economic and Quality of Life Effects of the RAINBOW Intervention to Treat Comorbid Obesity and Depression.

Authors:  Jeremy D Goldhaber-Fiebert; Lea Prince; Lan Xiao; Nan Lv; Lisa G Rosas; Elizabeth M Venditti; Megan A Lewis; Mark B Snowden; Jun Ma
Journal:  Obesity (Silver Spring)       Date:  2020-04-22       Impact factor: 5.002

6.  Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities.

Authors:  Christopher McCabe; Richard Edlin; David Meads; Chantelle Brown; Samer Kharroubi
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

7.  EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

Authors:  Mihir Gandhi; Marcus Ang; Kelvin Teo; Chee Wai Wong; Yvonne Chung-Hsi Wei; Rachel Lee-Yin Tan; Mathieu F Janssen; Nan Luo
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

8.  Plaster cast versus functional bracing for Achilles tendon rupture: the UKSTAR RCT.

Authors:  Matthew L Costa; Juul Achten; Susan Wagland; Ioana R Marian; Mandy Maredza; Michael Maia Schlüssel; Anna S Liew; Nick R Parsons; Susan J Dutton; Rebecca S Kearney; Sarah E Lamb; Benjamin Ollivere; Stavros Petrou
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

9.  Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation.

Authors:  Philip Riley; Anne-Marie Glenny; Helen V Worthington; Elisabet Jacobsen; Clare Robertson; Justin Durham; Stephen Davies; Helen Petersen; Dwayne Boyers
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

10.  An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.

Authors:  Lisa Shaw; Nawaraj Bhattarai; Robin Cant; Avril Drummond; Gary A Ford; Anne Forster; Richard Francis; Katie Hills; Denise Howel; Anne Marie Laverty; Christopher McKevitt; Peter McMeekin; Christopher Price; Elaine Stamp; Eleanor Stevens; Luke Vale; Helen Rodgers
Journal:  Health Technol Assess       Date:  2020-05       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.